Xencor Inc (XNCR)
24.11
+0.48
(+2.03%)
USD |
NASDAQ |
May 03, 16:00
24.10
-0.02
(-0.06%)
After-Hours: 20:00
Xencor Cash from Financing (Quarterly): 22.98M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.98M |
| September 30, 2023 | 0.356M |
| June 30, 2023 | 1.921M |
| March 31, 2023 | 0.922M |
| December 31, 2022 | 1.171M |
| September 30, 2022 | 1.287M |
| June 30, 2022 | 2.513M |
| March 31, 2022 | 0.731M |
| December 31, 2021 | 32.63M |
| September 30, 2021 | 3.229M |
| June 30, 2021 | 1.84M |
| March 31, 2021 | 5.339M |
| December 31, 2020 | 9.587M |
| September 30, 2020 | 2.986M |
| June 30, 2020 | 4.00M |
| March 31, 2020 | 1.471M |
| December 31, 2019 | 2.973M |
| September 30, 2019 | 3.049M |
| June 30, 2019 | 3.973M |
| March 31, 2019 | 0.667M |
| December 31, 2018 | 1.165M |
| September 30, 2018 | 4.153M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.308M |
| March 31, 2018 | 246.62M |
| December 31, 2017 | 0.621M |
| September 30, 2017 | 0.99M |
| June 30, 2017 | 1.096M |
| March 31, 2017 | 1.026M |
| December 31, 2016 | 119.80M |
| September 30, 2016 | 0.501M |
| June 30, 2016 | 0.473M |
| March 31, 2016 | 0.20M |
| December 31, 2015 | 0.387M |
| September 30, 2015 | 0.114M |
| June 30, 2015 | 0.33M |
| March 31, 2015 | 115.55M |
| December 31, 2014 | 0.177M |
| September 30, 2014 | -0.002M |
| June 30, 2014 | 0.131M |
| March 31, 2014 | 0.002M |
| December 31, 2013 | 72.51M |
| September 30, 2013 | 2.369M |
| June 30, 2013 | 7.514M |
| March 31, 2013 | -0.002M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.356M
Minimum
Sep 2023
32.63M
Maximum
Dec 2021
5.419M
Average
2.973M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 40.72M |
| Karyopharm Therapeutics Inc | 0.264M |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 181.21M |
| Cash from Investing (Quarterly) | -203.13M |
| Free Cash Flow | 63.86M |
| Free Cash Flow Per Share (Quarterly) | 2.950 |
| Free Cash Flow to Equity (Quarterly) | 158.53M |
| Free Cash Flow to Firm (Quarterly) | 179.50M |
| Free Cash Flow Yield | 4.40% |